ConductScience.org, home

Paper41775697

Transcriptional factor ZMYM3 promotes hepatocellular carcinoma metastasis by upregulating CTTN and inducing invadopodia formation.

Zeng F and 6 others. Cell Death Dis, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Transcriptional factor ZMYM3 promotes hepatocellular carcinoma metastasis by upregulating CTTN and inducing invadopodia formation. Papers, record 41775697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41775697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transcriptional factor ZMYM3 promotes hepatocellular carcinoma metastasis by upregulating CTTN and inducing invadopodia formation.
PubMed
Journal
Cell Death Dis
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zeng FFuling
2Zhang ZZihua
3Hu TTingting
4Xia XXin
5Lu DLDa-Linhttps://orcid.org/0000-0002-6896-6835
6Qu CChenhttps://orcid.org/0000-0002-6539-3197
7He LLuhttps://orcid.org/0000-0002-0391-0208

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Liver NeoplasmsMajor topic
Carcinoma, HepatocellularMajor topic
PodosomesMajor topic
CortactinMajor topic
Transcription FactorsMajor topic
Humans
Gene Expression Regulation, Neoplastic
Animals
Up-Regulation
Cell Line, Tumor
Epithelial-Mesenchymal Transition
Neoplasm Metastasis
Neoplasm Invasiveness
Cell Proliferation
Male
Female
Cell Movement
Mice, Nude
Prognosis
Mice

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82273154National Natural Science Foundation of China (National Science Foundation of China)PubMed
2023A1515012541Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province)PubMed
2025A04J5148Guangzhou Science, Technology and Innovation Commission (Bureau of Science and Information Technology of Guangzhou Municipality)PubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138682195CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway.Front Biosci (Landmark Ed)2024https://conductscience.org/library/papers/38682195PubMed
215464244Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma.J Hepatol2004https://conductscience.org/library/papers/15464244PubMed
337440829Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review.Chin J Cancer Res2023https://conductscience.org/library/papers/37440829PubMed
423843616Signaling inputs to invadopodia and podosomes.J Cell Sci2013https://conductscience.org/library/papers/23843616PubMed
514977600The role of dynamin in the assembly and function of podosomes and invadopodia.Front Biosci2004https://conductscience.org/library/papers/14977600PubMed
634876482Syntaxin4-Munc18c Interaction Promotes Breast Tumor Invasion and Metastasis by Regulating MT1-MMP Trafficking.Mol Cancer Res2022https://conductscience.org/library/papers/34876482PubMed
723518204Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma.World J Surg Oncol2013https://conductscience.org/library/papers/23518204PubMed
829172953Cortactin function in invadopodia.Small GTPases2020https://conductscience.org/library/papers/29172953PubMed
924305552Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.J Cell Mol Med2014https://conductscience.org/library/papers/24305552PubMed
1038098337POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1.Mol Oncol2024https://conductscience.org/library/papers/38098337PubMed
1133171811Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review.Int J Mol Sci2020https://conductscience.org/library/papers/33171811PubMed
1234194553Curcumin inhibits the viability, migration and invasion of papillary thyroid cancer cells by regulating the miR-301a-3p/STAT3 axis.Exp Ther Med2021https://conductscience.org/library/papers/34194553PubMed
1335008569Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression.Int J Mol Sci2021https://conductscience.org/library/papers/35008569PubMed
1439696702NOX proteins and ROS generation: role in invadopodia formation and cancer cell invasion.Biol Res2024https://conductscience.org/library/papers/39696702PubMed
1538436249Simultaneous Visualization and Depletion of Peroxynitrite by a Simple Aggregation-Induced Emission Nanoprobe for Preventing Breast Cancer Metastasis after Surgery.Anal Chem2024https://conductscience.org/library/papers/38436249PubMed
1634004332Focal adhesion dynamics in cellular function and disease.Cell Signal2021https://conductscience.org/library/papers/34004332PubMed
1738028589Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma.Front Genet2023https://conductscience.org/library/papers/38028589PubMed
1828242625ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.Genes Dev2017https://conductscience.org/library/papers/28242625PubMed
1938123132Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells.Ann Hepatol2024https://conductscience.org/library/papers/38123132PubMed
2031401293Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator.Semin Cancer Biol2020https://conductscience.org/library/papers/31401293PubMed

See all 40 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTTN2017PubTator's text mininghttps://conductscience.org/library/genes/2017NCBI Gene
ZMYM39203PubTator's text mininghttps://conductscience.org/library/genes/9203NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41775697

GET https://conductscience.org/api/papers/v1/41775697/references?page=2